BioLife Solutions - About the company
BioLife Solutions is an acquired company based in Bothell (United States), founded in 1987. It operates as a Developer of cell and gene therapies with the integrity of a single cell. BioLife Solutions has raised an undisclosed amount in funding, with last known valuation of $*****. The company has 594 active competitors, including 64 funded and 84 that have exited. Its top competitors include companies like Illumina, Siemens Healthineers and Quanterix.
Company Details
Developer of cell and gene therapies with the integrity of a single cell. The company provides biopreservation media like CryoStor Freeze Media, which supports clinical applications and maximizes post-thaw cell viability. Additional solutions include HypoThermosol for hypothermic storage, ThawSTAR automated thawing devices, and closed-system cell processing tools.
- Website
- www.biolifesolutions.com/
- Email ID
- *****@biolifesolutions.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
1987
Location
Bothell, United States
Stage
Acquired
Latest Funding Round
Last Known Valuation
$***** as on Jul 22, 2026
Ranked
6th among 594 active competitors
Employee Count
196 as on Sep 30, 2026
Exit Details
Acquired by Repligen (Jul 22, 2026)
Legal entities associated with BioLife Solutions
BioLife Solutions is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Biolife Solutions, Inc. CIN: 0018y00000BnLTeAAN , United States, Active | May 02, 2024 | - | - | - |
BioLife Solutions Inc CIN: 94-3076866 , United States, Active | Nov 04, 1987 | - | 409 (As on Dec 31, 2023) | - |
BIOLIFE SOLUTIONS, INC CIN: 943076866 , United States, Active | Dec 31, 1999 | - | 321 (As on Dec 31, 2024) | - |
BioLife Solutions's acquisition details
Click here to take a look at BioLife Solutions's acquisition in detail
Sign up to download BioLife Solutions' company profile
BioLife Solutions's funding and investors
BioLife Solutions has raised funding over 2 rounds. Its first funding round was on Apr 30, 2018.
Here is the list of recent funding rounds of BioLife Solutions:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 27, 2023 | 6567297 | Post IPO | 1401422 | 3072053 | 1566036 | 1757307 |
Apr 30, 2018 | 9756370 | Post IPO | 2272983 | 2164057 | 1177009 | 4535713 |
View details of BioLife Solutions's funding rounds and investors
BioLife Solutions' founders and board of directors
Founder? Claim ProfileBioLife Solutions' employee count trend
BioLife Solutions has 196 employees as of Sep 26. Here is BioLife Solutions's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BioLife Solutions's Competitors and alternates
Top competitors of BioLife Solutions include Illumina, Siemens Healthineers and Quanterix. Here is the list of Top 10 competitors of BioLife Solutions, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Illumina 1993, San Diego (United States), Public | Developer of technologies for analysis of genetic variation and function | $28M | 78/100 | |
2nd | Siemens Healthineers 2017, Forchheim (Germany), Public | Provider of medical imaging laboratory diagnostics and clinical digital solutions | - | 75/100 | |
3rd | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | 72/100 | |
4th | Biocare Medical 1997, Concord (United States), Acquired | Manufacturer of primary antibodies and instruments for immunohistochemistry applications | $85M | 67/100 | |
5th | Provider of gene sequencing instruments, reagents, equipment, and related products | $1B | 66/100 | ||
6th | BioLife Solutions 1987, Bothell (United States), Acquired | Developer of cell and gene therapies with the integrity of a single cell | - | - | 64/100 |
7th | Integrated DNA Technologies 1987, Coralville (United States), Acquired | Provider of oligonucleotide-based reagents and kits | - | 63/100 | |
8th | Bio Rad 1952, Hercules (United States), Public | Portfolio of products and services for life science research and clinical diagnostic markets | - | 60/100 | |
9th | Abselion 2018, Cambridge (United Kingdom), Series A | Provider of a benchtop instrument for protien research | $12.6M | 59/100 | |
10th | Applied BioCode 2008, Santa Fe Springs (United States), Public | Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications | $20.3M | 59/100 |
Looking for more details on BioLife Solutions's competitors? Click here to see the top ones
BioLife Solutions's Investments and acquisitions
BioLife Solutions has made 8 investments in companies including Pluristyx and iVexSol. BioLife Solutions has also acquired 5 companies including PanTHERA CryoSolutions and Sexton Biotechnologies.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 28, 2025 | Investments | 2015 | Seattle (United States) | |
Apr 07, 2025 | Acquisition | 2018 | Edmonton (Canada) | |
Jan 26, 2023 | Investments | 2018 | Toronto (Canada) |
See all investments and acquisitions by BioLife Solutions
Reports related to BioLife Solutions
Here is the latest report on BioLife Solutions's sector:
News related to BioLife Solutions
Media has covered BioLife Solutions for a total of 11 events in the last 1 year, 6 of them have been about company updates.
•
Repligen Completes Acquisition of BioLife SolutionsGlobeNewswire•Oct 06, 2026•BioLife Solutions, Repligen
•
The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS)PR Newswire•Jul 22, 2026•Monteverde, BioLife Solutions, Repligen, Luxfer and 2 others
•
Repligen to Acquire BioLife Solutions for $1.5 Billion, Expanding Cell Therapy CapabilitiesGlobeNewswire•Jul 22, 2026•BioLife Solutions, Repligen
•
Rockefeller Capital Management L.P. Cuts Stock Holdings in BioLife Solutions, Inc. $BLFSThemarketsdaily•Jun 24, 2026•BioLife Solutions, Rockefeller Capital Management
•
Life sciences firm planning $16M relocation to NoblesvilleInside INdiana Business•May 27, 2026•BioLife Solutions
•
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCasePR Newswire•Apr 21, 2026•BioLife Solutions
•
BioLife Solutions Signs Supply Agreement with Qkine LimitedBenzinga•Feb 12, 2026•Qkine, BioLife Solutions
•
Stephens Investment Management Group LLC Acquires 237,097 Shares of Maximus, Inc. $MMSMarketBeat•Jan 17, 2026•Maximus, Stephens Investment Management Group, Palomar Specialty Insurance, Ryan Specialty and 13 others
•
Summit Creek Advisors LLC Makes New Investment in BioLife Solutions, Inc. $BLFSMarketBeat•Jan 12, 2026•Summit Creek Advisors, BioLife Solutions
•
Forum Private Client Group LLC Acquires New Holdings in BioLife Solutions, Inc. $BLFSMarketBeat•Nov 24, 2025•BioLife Solutions, FORUM Credit Union
Are you a Founder ?
FAQs about BioLife Solutions
Explore our recently published companies
- Haase Nauen - Garbsen based, Unfunded company
- Niemerszein - Hamburg based, Unfunded company
- Infinity Share - Germany based, 2020 founded, Unfunded company
- Spedition Pape - Germany based, Unfunded company
- Estream International - Germany based, 2019 founded, Public company
- Genussakademie Bayern - Kulmbach based, 2017 founded, Unfunded company